Using STED super-resolution microscopy, researchers at the University of British Columbia have shed new light on the compartmentalization in peripheral ER tubules. Using the lumenal ER reporter ER monomeric oxidizing environment-optimized green fluorescent protein (ERmoxGFP), the team led by Dr. Ivan Nabi performed high-speed (40 ms/frame) live-cell STED imaging and characterized the behavior of the... Read more
WASHINGTON, Nov. 27, 2019 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Evercore ISI HealthCONx Conference on Thursday, December 5, 2019 at 8:45 a.m. ET. The audio will be simultaneously webcast and then archived on www.danaher.com. About DanaherDanaher is a global... Read more
Agilent Receives Multiple Life Science Industry Awards for Innovation Recognizing innovation and excellence in the life science industry SANTA CLARA, Calif., November 26, 2019 Agilent Technologies, Inc. (NYSE: A) announced today that it has received two Life Science Industry Awards (LSIA) for ‘Most Innovative New Products in 2019’ from BioInformatics Inc. Since 2002, the LSIA... Read more
https://www.agilent.com/about/newsroom/presrel/2019/25nov-gp19026.html Read more
Investment doubles the site’s process development capabilities and establishes commercial testing Read more
Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying HNSCC patients for treatment with KEYTRUDA® (pembrolizumab) in Europe SANTA CLARA, Calif., November 22, 2019 Agilent Technologies, Inc. (NYSE: A) today announced that its PD-L1... Read more
Agilent Announces Applications Open for LabCentral Golden Ticket Sponsorship will enable a promising biotech startup to advance scientific discovery SANTA CLARA, Calif., November 21, 2019 Agilent Technologies, Inc. (NYSE: A) has announced that the nomination process to submit proposals to receive an Agilent-sponsored LabCentral Golden Ticket is open for interested life sciences and biotech startup... Read more
Copeptin now in the new European Society of Cardiology Guidelines for the Diagnosis and Treatment of Pulmonary Embolism 2019 Copeptin mentioned as an important prognostic biomarker for risk stratification in patients with acute pulmonary embolism HENNIGSDORF, Germany, Nov. 21, 2019 /PRNewswire/ — Acute pulmonary embolism is one of the leading causes for cardiovascular death worldwide. Clinicians... Read more
Agilent Technologies Increases Cash Dividendto 18 Cents Per Share SANTA CLARA, Calif., November 20, 2019 Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 18 cents per share of common stock, reflecting a 10 percent increase over the previous quarter’s dividend. The dividend will be... Read more